Hqcheal 200 Tablet contains Hydroxychloroquine 200 mg, an antimalarial and immunomodulatory agent commonly used in the treatment and prevention of malaria, as well as autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. Hydroxychloroquine acts by interfering with the growth of parasites in red blood cells and modulating the immune system to reduce inflammation and tissue damage. It is indicated for the prophylaxis and treatment of uncomplicated malaria caused by Plasmodium species and as a disease-modifying antirheumatic drug (DMARD) in autoimmune conditions. The tablet should be administered orally with or without food, following the prescribed dosage regimen to minimize adverse effects. Common side effects may include gastrointestinal disturbances, headache, dizziness, and skin rash. Long-term use requires regular ophthalmologic monitoring due to the risk of retinopathy, which can lead to irreversible vision loss if undetected. Caution is advised in patients with pre-existing retinal or visual field abnormalities, hepatic or renal impairment, and those taking concomitant medications that may prolong the QT interval. Hqcheal 200 Tablet should be used under medical supervision, ensuring appropriate assessment and monitoring to optimize therapeutic outcomes and minimize risks.